Royalty Pharma - 2 Year Dividend History | RPRX

Historical dividend payout and yield for Royalty Pharma (RPRX) since 2022. The current TTM dividend payout for Royalty Pharma (RPRX) as of June 18, 2024 is $0.84. The current dividend yield for Royalty Pharma as of June 18, 2024 is 3.20%.
Sector Industry Market Cap Revenue
Finance Finance - Miscellaneous Services $15.689B $2.355B
Royalty Pharma plc is a funder of biopharmaceutical industry. The compnay's portfolio includes royalties on commercial products, including AbbVie and J&J's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Gilead's HIV franchise, Merck's Januvia, Novartis' Promacta and Vertex's Kalydeco, Symdeko and Trikafta, and development-stage product candidates. Royalty Pharma plc is based in NEW YORK.
Stock Name Country Market Cap PE Ratio